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Background: Trochanteric fractures are common fractures in the elderly. Due to characteristic demographic
changes, the incidence of these injuries is rapidly increasing. Treatment of these fractures is associated with high
rates of complications. In addition, the long-term results remain poor, with high morbidity, declines in function, and
high mortality. Therefore, in this study, complication rates and patients’ outcomes were evaluated after fixation of
geriatric trochanteric fractures using the Gamma3TM nail.
Methods: Patients aged 60 years old or older, with pertrochanteric and subtrochanteric femoral fractures, were
included. Patients with polytrauma or pathological fractures were excluded. Age, sex, and fracture type were
collected on admission. In addition, data were recorded concerning the surgeon (resident vs. consultant), time of
operation, and local or systemic perioperative complications. Complications were also collected at the 6- and
12-month follow-ups after trauma. Barthel Index, IADL, and EQ-5D measurements were evaluated retrospectively on
admission, as well as at discharge and during the follow-up.
Results: Ninety patients were prospectively included between April 2009 and September 2010. The patients’
average age was 81 years old, and their average ASA score was 3. The incision/suture time was 53 min
(95% CI 46–60 min). Hospital mortality was 4%, and overall mortality was 22% at the 12-month follow-up. Eight
local complications occurred (4 haematomas, 1 deep infection, 1 cutting out, 1 irritation of the iliotibial tract,
1 periosteosynthetic fracture). The incidence of relevant systemic complications was 6%. Forty-two percent of the
patients were operated on by residents in training, without significant differences in duration of surgery,
complication rate, or mortality rate. The Barthel Index (82 to 71, p < .001), IADL (4.5 to 4.3, p = .0195) and EQ-5-D
(0.75 to 0.66, p = .068) values did not reach pre-fracture levels during the follow-up period of 12 months.
Conclusion: The results showed a relatively low complication rate using the Gamma3TM nail, even if the nailing was
performed by residents in training. The high mortality, declines in function, and low quality of life could probably
be attributed to pre-existing conditions, such as physical status.
In summary, the Gamma3TM nail seems to be a useful implant for the nailing of trochanteric fractures, although
further studies are necessary comparing different currently available devices.
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Proximal femoral fractures are common fragility frac-
tures in the elderly. These injuries have been identified as
among the most serious health care problems affecting
the elderly [1]. The estimated costs of these fractures are
€2 billion to €4 billion per year in Germany [2]. World-
wide, the incidence of fractures of the proximal femur is
increasing because of a demographic transition resulting
in higher life expectancy [1,3-5]. For example, by 2050,
48% of the German population will be older than
65 years old, according to estimates from the Federal
Statistics Office of Germany [6]. Trochanteric and sub-
trochanteric fractures amount to approximately half of
proximal femoral fractures [7]. These fractures will occur
more often in the future. Thus, the successful treatment
of these fractures is becoming increasingly important.
In the infancy of the surgical treatment of trochanteric
fractures, rigid combinations of femoral nails with lateral
plates were used. High rates of cutting out, metal failure,
or secondary fracture displacement were reported. Sub-
sequently, dynamic fixation was introduced with the
Ender nail or with the compression hip screw [8]. The
sliding hip screw became the standard of care in these
fractures for many years, with good results in minimally
displaced and stable fractures. However, this osteosynth-
esis has not proved successful in complicated trochan-
teric fractures [9]. It is for this reason that intramedullary
implants have been increasingly used as an alternative
for these fracture types.
The first version of this intramedullary device was the
GammaTM nail. It was the first device that could be
implanted minimally invasively, and it promised certain
biomechanical advantages.
Initial randomised, controlled trials in the early 1990s,
comparing the sliding hip screw with the GammaTM nail,
showed high complication rates with the intramedullary
implant, such as femoral shaft fractures [10-13]. Conse-
quently, modifications of the GammaTM nail have been
made in recent decades. The diameter of the nail and
the valgus ankle were reduced, the lag screw and the
targeting device were modified, and a dynamic distal
locking option was added, constituting the main changes
in the development to the actual Gamma 3TM nail.
Meanwhile, internationally, many authors have recom-
mended the treatment of unstable pertrochanteric frac-
tures with modern intramedullary implants because of
their higher loading capacity and the broad scope of
their potential application [14-17]. Evidence exists that
intertrochanteric fractures (A3 fractures, according to
the AO/OTA classification) of the proximal femur are
best treated with intramedullary devices. The best treat-
ment is unclear of A2 fractures with dislocation of the
lesser trochanter. Some authors still prefer the sliding
hip screw for osteosynthesis [18].Over the past few years, the Gamma3TM nail was
established in our department for two reasons. Firstly, it
can be used for various fractures, e.g., subtrochanteric
fractures. Secondly, the Gamma3TM nail offers standar-
dised and easy handling of the instrumentarium. This
ease of use is especially useful in a teaching hospital, in
which less experienced residents in training might
already utilise it.
To date, there have been few data available on the use
of the Gamma3TM nail in geriatric trochanteric and in
subtrochanteric fractures in particular. The aim of this
study was to report our experiences with the implemen-
tation of the Gamma3TM nail and our patients’ outcomes
in a prospective clinical trial. The actual health care situ-
ation should be illustrated. Therefore, few exclusion cri-
teria were applied. In contrast to other trials in particular,
multimorbid patients and patients with dementia were
included.
Methods
In our study, patients at least 60 years old were included
in this prospective, single-centre, observational study
with pertrochanteric and subtrochanteric femoral frac-
tures (ICD 10 S 72.1-72.2)[19].
The criteria for exclusion were polytrauma (ISS≥16)
and fractures caused by malignancies or metastases. All of
the patients were surgically treated with the Gamma3TM
nail (Stryker, Schönkirchen, Germany). The inclusion
period was from 1 April, 2009, to 30 September, 2010.
Two follow-up visits were performed at 6 and 12 months
after trauma, so the observation period ended on 30
September, 2011. Approval of the Ethics Committee of
the University of Marburg was obtained (AZ 175/08).
Each of the patients gave his or her written consent.
Next, personal data (sex, age) were collected, as well
as ASA score, fracture side, and fracture type. The
fractures were differentiated according to the AO/OTA
classifications for pertrochanteric and subtrochanteric
fractures [20].
Data concerning the interval between admission and
surgery, the operating time (cutting to suture time), and
the operating surgeon were also collected. The surgeons
were divided into residents in training and consultants.
Local complications that required surgical intervention
were also registered during the hospitalisation period and
the follow-up. In addition, systemic perioperative compli-
cations, such as cardiac infarctions, strokes, thromboses,
and embolisms, were recorded. In-hospital mortality and
mortality in the follow-up period were also noted.
The patients were requested to provide information
about their function and health-related quality of life retro-
spectively. The measurements of functional status were
the Barthel Index (BI), according to the Hamburg Classifi-
cation Manual [21], and the Instrumental Activities of
Table 1 Patients characteristics
Data All patients (n=90)







Barthel Index (±SD) (95% C e) 82 (±23) (77-87)
ASA* classification (±SD) (95% C) 2.9 (±0.5) (2.8-3.1)
ASA 1 1 (1%)
ASA 2 14 (16%)
ASA 3 65 (72%)
ASA 4 10 (11%)
*ASA = American Society of Anesthesiologists.
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EQ-5D Index was calculated using the additive lean
model, which was described by Greiner et al. [23]. The
Barthel Index, the IADL, and the EQ-5D were adminis-
tered at discharge and during follow-up.
The data were collected into a FilemakerW (FileMaker
Inc., Santa Clara, CA, USA) database. Double entry
with a plausibility check was performed to improve the
data quality.
Predictive Analysis SoftWare (PASWW), version 18.0
(SPSS Inc., Chicago, IL, USA), was used for the data ana-
lysis. Descriptive statistics and explorative data analysis
were performed. The frequencies for dichotomous vari-
ables and the means, standard deviations, and confidence
intervals were determined for continuous variables. The
patients were divided into different groups: patients with-
out complications, patients with complications, deceased
patients, and patients who were operated on either by a
resident or by a consultant. Differences in length of hos-
pital stay and duration of surgery between patients
who were operated on by residents and by consultants
were determined by the Mann–Whitney-U test. The chi-
square test was performed to determine differences in
the occurrence of local and general complications and
mortality. The various results of the Barthel Index, the
IADL, and the EQ-5D, prefracture and at the follow-up
visits, were compared with the Mann–Whitney-U test.
For all of the tests, statistical significance was assumed
at p < .05.
Surgical technique and perioperative treatment
Osteosynthesis was usually performed under general
anaesthesia. The patients were positioned supine on a
traction table. Initially, a closed reduction by axial traction
was performed under fluoroscopy. Then, osteosynthesis
was performed as previously described [24]. For trochan-
teric fractures, the Gamma3TM trochanteric nail (Stryker,
Schönkirchen, Germany), with a diameter of 11 mm, a
length of 180 mm, and a lag screw angle of 125° or 130°,
was used. The long Gamma3TM nail (360 mm–440 mm)
was used for subtrochanteric fractures. If necessary, an
open reduction was performed, and a cable wire was
used before the nail was inserted. The perioperative
treatment of the patients did not vary through participa-
tion in this study. All of the patients were treated accord-
ing to our in-house standards. This process included
each of the patients being monitored postoperatively in
our intensive care unit. The patients were mobilised on
the first postsurgical day with full weight-bearing.
Results
Out of 90 patients who were included in the present
study, 77% were female, and 23% were male. The average
age of all of the patients was 81 years old (95% CI 79–82years). Concerning physical status, most of the patients
were classified in the group with ASA 3, with 72% over-
all. Eleven percent were classified in ASA 4, and 16% in
ASA 2. Only 1% of our patients were healthy or had only
mild systemic disease (Table 1).
The right-to-left proportion of the fractured side
totalled 50:40. In total, we treated 88% trochanteric frac-
tures, with only 12% of the fractures being classified as
subtrochanteric fractures. In the trochanteric group,
most of the fractures we classified in A1 to AO classifica-
tion, with 36%. Thirty-three percent were A2 fractures,
and 19% were A3 fractures. In the subtrochanteric group,
we found 9% A1 and 2% A2 subtrochanteric fractures,
according to all of the patients. Only 1 patient had an
unstable A3 subtrochanteric fracture (Table 2).
In 78% (70 patients) of the cases, surgery was per-
formed within 24 hours after admission. Only 1 patient
was operated on after more than 48 hours (53 hours),
to improve physical conditions before surgery. In total,
16 surgeons (9 consultants, 7 residents) performed the
osteosynthesis procedures. Forty-two percent (n=38) of
all of the surgeries were performed by residents, with
an average experience of 3 years of residency, under the
supervision of consultants. Fifty-seven percent (n=52)
of all of the operations were performed by consultants
themselves. The characteristics of these 2 groups of
patients do not differ substantially. Patients who were
operated on by residents were slightly younger and had
marginally higher average ASA scores and Barthel indi-
ces (Table 3). The relationship of operations in the tro-
chanteric group was relatively balanced between surgery
by residents and surgery by consultants, with proportions
of 54% and 45%. Unlike in the trochanteric group, only
18% of the subtrochanteric fractures were operated on
by residents, while 82% of the procedures were per-
formed by consultants. The duration of surgery for all of
Table 2 Fracture type, duration of surgery by qualification of the surgeons
Data All patients (n=90)
Qualification of surgeon
Consultant (n=52) Resident (n=38)
Fracture type*
trochanteric A1 32 (36%) 17 (33%) 15 (39%)
trochanteric A2 30 (33%) 17 (33%) 13 (34%)
trochanteric A3 17 (19%) 9 (17%) 8 (21%)
subtrochanteric A1 8 (9%) 7 (13%) -
subtrochanteric A2 2 (2%) 1 (2%) 1 (3%)
subtrochanteric A3 1 (1%) 1 (2%) 1 (3%)
Duration of surgery in min (±SD) (95% CI) 53 (±31) (46-60) 54 (±34) (45-64) 52 (±29) (42-61)**
Time of hospitalization in days (±SD) (95% CI) 14.1 (±5.1) (13.0-15.2) 14.3 (±5.7) (12.7-15.9) 13.9 (± 4.3) *** (12.5-15.3)
*according to the AO classification.
**p=0.790.
***p=0.461
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a range from 19 to 180 minutes. On average, consultants
needed 54 minutes, while residents required 52 minutes
for surgery (Table 2).
The time of hospitalisation, on average, was 14.1 days
(95% CI 13.0-15.2 days).
During hospitalisation, some general complications
occurred after surgery. One patient suffered a myocardial
infarction, and 1 case of pneumonia and 2 apoplexies
were counted in different patients. One patient suffered
a ventricular fibrillation during ICU monitoring and was
revived successfully.
During hospitalisation, 4 patients died. Two of them
had cardio-pulmonary decompensation, 1 had multiple
organ failure, and 1 had a cause of death that was un-
known (Table 4).
In addition, some local complications occurred without








mean (±SD) 80 (±8.1) 82 (±6.4)
95% CI 78.5 – 82.3 78.4 – 86.6
Barthel Index
mean (±SD) 82 (±23) 80 (±19)
95% CI 77 - 88 67 - 93
ASA* classification
mean (±SD) 2.9 (±0.6) 2.9 (±0.3)
95% CI 2.8 – 3.1 2.7 – 3.1
*ASA = American Society of Anesthesiologists.
** p<0.001 in comparison to survivors.
*** p=0.02.(Table 4). We counted 4 postoperative haematomas
and 1 deep infection. Two of the patients with post-
operative haematomas received anticoagulants because
of pre-existing atrial fibrillation. A third patient had an
idiopathic coagulation disorder. One of the haematomas
and the infection required surgical interventions. The
haematoma was cured in a single step. Three of the hae-
matomas were monitored and treated conservatively.
The deep infection was caused by Staphylococcus aureus.
Several surgical revisions were necessary. The patient
died during one of the revisions due to heart failure. The
deep infection, which occurred in a patient with a A1
trochanteric fracture, and 3 of the 4 haematomas
appeared after surgery by consultants (Table 4). The
initial fractures of patients with haematoma were 3 stable
A1 and 1 A2 trochanteric fractures.
Implant failures were found in 3 cases during follow-up.








82 (±7.7) 83 (±7.2) 78 (±7.9)
78 - 85 81 - 85 75 - 80
75 (±25) 80 (±24)*** 84 (±21)***
62 - 87 73 - 87 77 - 91
3.4 (±0.6)** 2.9 (±0.5) 3.0 (±0.6)
3.1 - 3.6 2.7 – 3.0 2.8 – 3.2




Consultant (n=52) Resident (n=38)
General in hospital Complication 5 (5.6%) 3 (5.8%) 2 (5.3%) 0.918
Apoplexy 2 1 1
Embolism 0 - -
Myocardial infarction 1 - 1
Ventricular fibrillation 1 1 -
Pneumonia 1 1 -
Thrombosis 0 - -
Mortality
In hospital 4 (4.4%) 4 (7.7%) 0 (0.0%) 0.080
6 month 16 (17.8%) 9 (17.3%) 7 (18.4%) 0.891
12 month 20 (22.2%) 10 (19.2%) 10 (26.3) 0.425
Local complications 8 (8.9%) 4 (7.7%) 4 (10.5) 0.641
Cutting out 1 - 1
Hematoma 4 3 1
Deep Infection 1 1 -
Periosteosynthetic fracture 1 - 1
Tractus irritation 1 - 1
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tract irritation (A2 trochanteric fracture), and 1 periosteo-
synthetic fracture (A2 subtrochanteric fracture) occurred.
Concerning the cutting out, the nail was removed, and
a hip arthroplasty was performed (Figure 1). In the case
of tract irritation, only the hip screw was changed with-
out any problems (Figure 2). The patient who suffered
the periosteosynthetic fracture was initially treated with a
long nail because of a subtrochanteric fracture. The nail
was left in, and a plate osteosynthesis was performed
without further complications (Figure 3).
Table 3 compares the characteristics of the patients
who suffered one of the complications described above,Figure 1 Patient with cutting out: postoperative, during follow-
up and after revision with hip prosthesis.along with the patients who died before the 12-month
follow-up. In addition, the patients who neither died nor
suffered a complication are described. Patient who were
operated on by consultants were significant younger
(80 years old, p = .02) than patients who were operated
on by residents (84 years old). The average ASA score
was higher in patients who died within 12 months in
comparison to the survivors (p < .001). There were no
further significant differences between the patients’
characteristics (Table 3).
For the measurement of health status and outcome,
several indices were applied. The Barthel Index andFigure 2 Patient with tract irritation: postoperative, during
follow-up and after revision with change of the femoral neck
screw.
Figure 3 Patient with peri-osteosynthetic fracture:
postoperatively, during follow-up and after revision with plate
osteosynthesis.
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mentia by their relatives. Overall, preoperatively and at
hospital release, the Barthel indices of 85 and 86 patients
were determined, respectively. The index was 82 (95%
CI 77–87) preoperatively and, on average, was lower (50;
95% CI 44–56, p < .001) at hospital release (Figure 4).
The IADL of the 85 patients preoperatively was 4.5 on
average (95% CI 3.9-5.1) (Figure 5).
The preoperatively determined EQ-5D Index of 74
patients was 0.75 on average (95% CI 0.69-0.80, Figure 6).
Sixteen patients could not provide full particulars be-
cause of severe dementia.
Follow-up
All of the patients or their relatives or general practi-
tioners could be contacted and asked about complica-
tions or death. Thus, 13 of the 74 patients who were still


















Figure 4 Barthel Index: pretraumatic, at 6 month follow up and at 12for the other outcome parameters. At 12 months, 1 more
patient was lost to follow-up. The overall follow-up rate
was 76 patients out of 90 patients, or 84%.Mortality
Twelve patients died during the first 6 months, and
another 4 patients died before 1 year was reached. Thus,
12-month mortality totalled 22% without a difference
between the surgeons (Table 4).Barthel Index and IADL
The Barthel Index increased by approximately 47%
(73 index points, 95% CI 66–81) in relation to the
status at the hospital release of the patients at 6 months
(p < .001) but was vaguely similar to the index at follow-
up, with 71 index points (95% CI 62–81, p = .448), on
average, at 12 months (Figure 4). The Instrumental
Activities Of Daily Living (IADL) scale amounted to
4.3 on average after 6 months (95% CI 3.4-5.1) and was
similar, with 4.3 points on average at 12 months as well
(95% CI 3.4-5.3, p = .668) (Figure 5).Health-related quality of life
The EQ-5D index decreased by approximately 23%
(0.58 index points, 95% CI 0.49-0.67, p < .001) after
6 months compared to the preoperative status. Thus, in
relation to the 6-month follow-up, the EQ-5D index
increased by approximately 11% (0.66 index points, 95%
CI 0.58-0.75, p = .012) after 12 months; however, it
undermatched the preoperative status by roughly 11%
on average, without reaching a significant difference
(p = .068, Figure 6).at 6 month at 12 month
 < 0.001















p = 0.070 p = 0.668
Figure 5 Activities of daily living: pretraumatic, at 6 month follow up and at 12 month follow up.
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Trochanteric and subtrochanteric fractures are common
fragility fractures in the elderly. While the incidence of
proximal femoral fractures is increasing because of
demographic transitions [6] in Germany and worldwide
[1,3,4], an increase in trochanteric and subtrochanteric
fracture incidence can also be predicted. Today, prox-
imal femoral fractures, as typical fragility fractures, are
of great socio-economic importance [25].
With its distribution by sex, age, and ASA score
(Table 1), our patient collective was typical of fragility
fractures of the proximal femur. Studies have shown





















Figure 6 EQ-5D Index: pretraumatic, at 6 month follow up and at 1250% disposition to ASA classification 3 or 4 [21,26]. The
division in this study of different trochanteric and sub-
trochanteric fracture types also approximately con-
formed to other studies [27,28]. Thus, our results are
comparable to other publications.
To date, the optimal choice for the stabilisation of tro-
chanteric fractures remains controversial because there
is still a lack of evidence for the use of intramedullary
devices, instead of extramedullary devices [9].
Only for A3 fractures of the proximal femur there is
evidence that these fractures are best treated with intra-
medullary devices. The sliding hip screw is sometimes
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intramedullary devices for the treatment of trochanteric
and subtrochanteric fractures. We only implant sliding
hip screws for non-displaced femoral neck fractures.
To date, there have been few data available on the
use of the Gamma3TM nail in geriatric trochanteric and
subtrochanteric fractures in particular. Yaozeng et al.
reported good results with the Gamma3TM nail [29],
but most of the publications in this context have dealt
with the first generation of GammaTM nail or with other
cephalomedullary devices [9]. Improvements of the
Gamma3TM nail include a reduction of the diameter of
the nail, a change to the valgus angle from 10º to 4º,
changes in the design of the femoral neck screw, and
the possibility of dynamisation [30].
The aim of this study was to report our experiences
with the implantation of the Gamma3TM nail in a pro-
spective, clinical trial. During the observation period,
90 patients who met the inclusion criteria were included
in our study.
It could be shown that Gamma3TM nailing was per-
formed by residents in training under the supervision of
consults in nearly half of our cases (Table 2). This find-
ing is of great importance in the consideration of further
medical education for young physicians, especially in a
university hospital setting. One study recently showed
that teaching hospitals are $6,000 more expensive in the
United States in the operative management of hip frac-
tures. In this context, the 6-month mortality was 1.4%
lower than in non-teaching hospitals [31]. In consider-
ation of the duration of surgery and the incidence of
complications, such great differences in medical care by
residents in training and by consultants appeared less
likely in our patient collective (Table 2). The patient char-
acteristics were similar between the patients who under-
went surgery by residents and by consultants (Table 3).
However, only 2 of 11 subtrochanteric fracture osteo-
synthesis procedures were performed by residents. This
finding might be an indication of the complexity of this
type of fracture. In contrast, in the study of Westacott
et al., 50% of the surgeries were performed by residents
in training [32]. In-hospital mortality (11%) and 1-year
mortality (28%) in that study were not affected only by
the qualifications of the surgeons. Unfortunately, ana-
lyses of further outcome parameters by surgeons were
not provided by Westacott et al. [32].
In addition, mechanical failures occurred after surgery
by residents in training, emphasising the great import-
ance of good instruction and careful handling when using
the Gamma 3 nail for trochanteric fractures (Table 4).
The incidence in our own collective of mechanical fail-
ures of 3.3% was lower than the rate reported in actual
literature [9-13]. We found 3 implant-related complica-
tions during follow-up. Cutting out, tract irritation, andperiosteosynthetic fracture occurred only once each. All
of these cases required additional surgery but were trea-
ted successfully (Figures 1, 2 and 3).
Cutting out is a familiar problem in the osteosynthesis
of trochanteric femoral fractures. The meta-analysis of
Audige et al. showed an incidence of cutting out in tro-
chanteric fracture surgery of 3.4% with nailing and 1.9%
with gliding hip screws [33]. Parker found similar results
[9]. In randomised trial, Stern et al. found no difference
concerning the cutting out rate when comparing screws
to helical blades on either DHS or intramedullary nail
[34]. Overall, they found a cutting out rate of 2.2%.
Because the tip-apex distance < 25 mm, and the “centre-
centre” position of the screw/blade was shown to be
advantageous, Stern et al. found 16% of cases with an
tip-apex distance > 25 mm and a “centre-centre” position
in only 80% of cases [35]. This finding might explain the
cutting out rate. We did not perform radiographic exami-
nations in our study, but we found incorrect placement
of the femoral neck screw in the only patient with cutting
out in the patient sample examined. In the affected pa-
tient, the nail was removed, and a hip arthroplasty was
performed with a good result.
Another common complication after surgery for tro-
chanteric fractures is iliotibial tract irritation [36]. Only
1 iliotibial tract irritation was seen in our patient sample
that required surgery. The femoral neck screw was
replaced successfully without any problems.
A periosteosynthetic fracture occurred after the osteo-
synthesis of 1 of the subtrochanteric fractures and was
managed with plate osteosynthesis. According to the
authors’ opinion, in the area at the end of the nail, the
stress of the femoral shaft was too great. Use of longer
nails that extend to the femoral condyle in subtrochan-
teric fractures could be a solution to this problem.
According to our results, in recent studies, the inci-
dences of perioperative and postoperative femoral frac-
tures after osteosynthesis of trochanteric fractures have
decreased, in comparison to older studies. It can be
assumed that previous concerns about increased femoral
shaft fracture risks with GammaTM nails have been
resolved, with improved implant design and improved
learning curves [37].
Our incidence of haematomas seemed to be high
(Table 2), but it did not exceed the range in other clin-
ical findings. Wound complications of up to 10% have
been described [38]. Only 1 of the haematomas in our
collective (1.1%) required surgery and was cured in a
single step. Our incidence of deep wound infections was
consistent with the literature [9]. In the 1 case of deep
wound infection, several surgical revisions were necessary.
Unfortunately, the patient died of heart failure during 1 of
the revisions. Interestingly, 4 of 5 soft tissue complications
appeared after surgery by consultants (Table 4), although
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explanation for 3 of the 4 postoperative haematomas
might have been iatrogenic or idiopathic coagulation
disorders.
Fortunately, neither intraoperative complications nor
non-unions were recorded. The latter finding can probably
be explained by the correct repositioning of the fractures.
However, perhaps some non-unions were not detected
because X-rays were only performed during follow-up in
cases of pain during weight-bearing.
Hospital mortality was 4%, and 1-year mortality was
22% in this study. These rates are low in comparison to
recent studies. For example, Barton found a 30-day mor-
tality of 21% and a 1-year mortality of 32% in patients
with similar characteristics [39]. The meta-analysis of
Liu showed a mortality of 22%[40]. However, in Liu’s
analysis, only 2 out of 7 studies had a 1-year follow up.
The other 5 studies only had a follow-up period of
6 months or less. In addition, some of the analysed
patients were younger than our patients.
Thus, the mortality of our patients was more than double
the age-specific mortality rate in Germany. Therefore, the
actual mortality rate between 80 and 84 years of age is
approximately 5.9% for women and 8.5% for men [41].
The Barthel Index and IADL measurements are inter-
nationally accepted assessments for functional physical
outcomes in geriatric patients. The Barthel Index was
also identified as a strong predictive factor for long-term
outcomes after hip fractures [42].
Long-term disability associated with hip fractures has
been described in many studies [43]. As expected, the
functional status at hospital release tends to decrease. It
could be shown that patients improve during follow-up.
Certainly, these pretraumatic IADL and Barthel Index
values were not reached, as in other studies (Figures 4
and 5) [44].
The Barthel Index fell slightly between the 6- and
12-month follow-ups (Figure 4). According to this find-
ing, even with a 2-year follow-up period, excessive dis-
ability, attributable to initial hip fracture, was observed
by Magaziner [45]. Overall, the values in our patient
collective exceeded the findings of other studies.
Kammerlander found a Barthel Index of 49.6 in long-
term functional outcomes after hip fractures. However,
the patients in that study were older, and the follow-up
period was longer (4.9 years) [46]. Thus, over time, fur-
ther follow-up is planned to obtain more information
about the long-term status of the patients.
The EQ-5-D levels were higher at different times of
assessment than the levels reported by Ekström et al.,
although that study only included patients with stable
trochanteric fractures. Consequently, the pretraumatic
EQ-5D was 0.69, with a value of 0.59 at 12-month follow-
up [47]. Concerning femoral neck fractures, a lowerquality of life could be shown for displaced, rather than
undisplaced, fractures [48]. On the one hand, it can be
shown that the EQ-5D values differ between different
countries, with higher values for German patients [23].
On the other hand, the trends over the period examined
were nearly the same. In this context, it might be inter-
esting to perform more follow-ups later, because Ekström
et al. observed an increase of up to 0.66 after 24 months.
Interestingly, the Barthel Index fell between the 6- and
12-month follow-ups, while the EQ-5-D Index increased
from 0.58 to 0.66 (Figures 4 and 6). It could be that
patients become increasingly accustomed to their func-
tional status over time. Furthermore, König et al. showed
that even nearly 70% of average citizens aged between
80 and 84 years old report moderate or extreme problems
in 1 of the 5 dimensions of the EQ-5-D. Unfortunately,
the EQ-5-D indices were not calculated in this article.
However, all in all, this finding indicates that health-
related quality of life is restricted, even in the normal
ageing population, emphasising the good long-term
results of this study.
Mortality, decline in function, and poor quality of life
could be attributed in large part to pre-existing condi-
tions. Table 3 shows the characteristics of the different
patient groups. Patient who were operated on by con-
sultants were younger and in patients who died within
12 months the average ASA score was higher in in
comparison to the survivors. There were no further stat-
istical differences (Table 3). However, some trends indi-
cate that patients who suffer complications are older, are
more diseased, and have worse pretraumatic functional
statuses. With more patients, including with other types
of hip fractures, the predictive value of these parameters
could be analysed in detail.
One of the limitations of this study is the retrospective
assessment of the Barthel Index, IADL, and EQ-5-D for
pre-existing conditions, which allows for bias. Unfortu-
nately, some patients were too senile to provide all of
their information. Last but not least, we did not perform
a comparison of 2 implants or of surgical procedures,
which is why a definitive recommendation of the Gamma
3TM nail cannot be provided based on this study.
In summary, we successfully illustrated an actual med-
ical care situation concerning the treatment of geriatric
trochanteric fractures in our department.
Conclusion
Surgical treatment of trochanteric fractures with the
Gamma3TM nail seems to be a quick and safe procedure,
even in vulnerable patient samples. The procedure can
also be successfully performed by residents in training,
although valuable guidance by consultants seems to be ne-
cessary in this kind of surgery. The use of the Gamma3TM
could be an improvement in surgery, compared to older
Buecking et al. BMC Research Notes 2012, 5:651 Page 10 of 11
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ducted to compare currently available devices for the
osteosynthesis of trochanteric fractures.
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